CEO Interviews

More Interviews

Greenwich LifeSciences (NASDAQ: GLSI)

Greenwich: Phase 3 Trial Actively Enrolling Patients Targeting Breast Cancer Recurrence

Greenwich LifeSciences (NASDAQ: GLSI) is a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery.

 Play

Inspira Technologies (NASDAQ: IINN)

Inspira: Game-Changing Solutions for Improved Patient Outcomes

Inspira Technologies Oxy B.H.N. Ltd. (“Inspira Technologies” or the “Company”) is an innovative medical technology company in the acute respiratory-failure arena. The Company has developed a breakthrough Augmented Respiration Technology (ART™), designed to rebalance patient oxygen saturation levels.

 Play

Recruiter.com (NASDAQ: RCRT)

Recruiter: Flexible Talent Acquisition Solutions

Recruiter.com (NASDAQ: RCRT) is an OnDemand recruiting platform providing flexible talent acquisition solutions that scale from startups to the Fortune 100. With an on-tap network of thousands of recruiting professionals and recruitment marketing automation, Recruiter.com helps businesses solve today's complex hiring challenges.

 Play

Draganfly (NASDAQ: DPRO)

Draganfly: The Longest-Standing Commercial Drone Manufacturer

Draganfly (NASDAQ: DPRO) has been a leader in the professional drone industry for more than 20 years, supporting clients with enterprise drone solutions, contract engineering services, custom software, professional unmanned aerial vehicle (UAV) services, and more. From public safety to pop culture, Draganfly has shaped not just the UAV industry, but the way people around the world work and live.

 Play

BioVie (NASDAQ: BIVI)

BioVie: Positive Data from Phase 2 Alzheimer’s and Parkinson’s Trials

BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI.

 Play

Rail Vision (NASDAQ: RVSN)

AI Driven Railway Safety Platform Attracts Major Investors

Rail Vision (NASDAQ: RVSN) is a development stage technology company that is seeking to revolutionize railway safety and the data-related market. The company has developed cutting edge, artificial intelligence based, industry-leading technology specifically designed for railways.

 Play


"I work with many of the companies that would be RedChip companies. And we certainly ascribe to the same view that the RedChip Companies do, which is Discovering Tomorrow's Blue Chips Today."

  • Bob McCooey, Senior Vice President, NASDAQ Stock Market